Alnylam Pharmaceuticals Inc (NASDAQ:ALNY)

171.52
Delayed Data
As of Sep 22
 -2.33 / -1.34%
Today’s Change
169.85
Today|||52-Week Range
242.97
-27.83%
Year-to-Date

Stock Price Forecast

The 24 analysts offering 12-month price forecasts for Alnylam Pharmaceuticals Inc have a median target of 250.00, with a high estimate of 405.00 and a low estimate of 134.00. The median estimate represents a +45.76% increase from the last price of 171.52.

Analyst Recommendations

The current consensus among 27 polled investment analysts is to Buy stock in Alnylam Pharmaceuticals Inc. This rating has held steady since September, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$1.53
Sales
$350.8M
Reporting Date
Oct 26

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 30.99%
 
 
 
 
 
 
Growthannually 34.66%
 
 
 
 
 
 

Sales

Growthquarterly 10.06%
 
 
 
 
 
 
Growthannually 34.02%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.